New Treatment Options for Patients with Advanced Neuroendocrine Tumors

ISSN： 1527-2729

Source： Current Treatment Options in Oncology, Vol.12, Iss.2, 2011-06, pp. : 136-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of pemetrexed in patients with advanced neuroendocrine tumors

By Chan Jennifer Zhu Andrew Stuart Keith Bhargava Pankaj Earle Craig Clark Jeffrey Casey Carolyn Regan Eileen Kulke Matthew

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 961-968

Springer Publishing Company

Access to resources Recommend Favorite

Anorexia: Treatment Options for Patients with Advanced Cancer

By Jatoi A.

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 269-275

Adis International

Access to resources Recommend Favorite

Somatostatin analogs for the treatment of neuroendocrine tumors

By Culler Michael Öberg Kjell Arnold Rudolf Krenning Eric Sevilla Isabel Díaz José

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 9-17

Springer Publishing Company

Access to resources Recommend Favorite

Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors

By Kaubisch Andreas Kaleya Ron Haynes Hilda Rozenblit Alla Wadler Scott

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 337-340

Springer Publishing Company

Access to resources Recommend Favorite

A useful treatment for patients with advanced mixed-type small cell neuroendocrine carcinoma of the prostate: A case report

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 793-796

Spandidos Publications

Access to resources Recommend Favorite